Is it clinically useful to repeat a pap smear at colposcopy?

Journal of Lower Genital Tract Disease

Volumn 7, Issue 4, 2003, Pages 271-278

  Mierlak, Julian A ^a,b  

^a Gouverneur Healthcare Hospital   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colposcopy; Management; Pap smear

Indexed keywords

ADENOCARCINOMA; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; COLPOSCOPY; DATA BASE; DISEASE SEVERITY; ELECTROSURGERY; ETHNOLOGY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; OUTCOMES RESEARCH; PAPANICOLAOU TEST; TIME; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; UTERINE CERVIX TUMOR;

EID: 0242351965     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/00128360-200310000-00008     Document Type: Article

References (39)

1. Noller KL. When one more Pap smear is one too many (editorial). Gynecol Oncol 1997;67:1-2.
2. Stafl A. Cervical intraepithelial neoplasia. In: Thompson JD, Rock JA, eds. Te Linde's Operative Gynecology. 7th ed. Philadelphia: JB Lippincott Company; 1992:1141-59.
3. Anderson MC, Jordan JA, Morse AR, Sharp F. Integrated Colposcopy. 2nd ed. London: Chapman and Hall; 1996.
4. Coppleson M, Pixley E, Reid B. Colposcopy: A Scientific and Practical Approach to the Cervix, Vagina, and Vulva in Health and Disease. 3rd ed. Springfield, IL: Charles C. Thomas; 1986.
5. Morris M. Preinvasive lesions of the female genital tract. In: Kase N, Weingold AB, Gershenson DM, eds. Principles and Practice of Clinical Gynecology. 2nd ed. New York: Churchill Livingstone; 1990:801-25.
6. American College of Obstetricians and Gynecologists. Cervical Cytology: Evaluation and Management of Abnormalities. ACOG Technical Bulletin No. 183. Washington, DC: American College of Obstetricians and Gynecologists, 1993.
7. Soutter P. A Practical Guide to Colposcopy. New York: Oxford University Press; 1993.
8. Julian TM. A Manual of Clinical Colposcopy. Pearl River, NY: The Parthenon Publishing Group Inc; 1998.
9. DiSaia PJ, Creasman WT. Clinical Gynecologic Oncology. 6th ed. St. Louis: CV Mosby Inc; 2002.
10. Bishop JW, Hartinger JS, Pawlick GF. Time interval effect on repeat cervical smear results. Acta Cytol 1997;41:269-76.
11. Zardawi IM, Rode JW. Clinical value of repeat Pap smear at the time of colposcopy. Acta Cytol 2002;46:495-8.
12. Wheelock JB, Kaminski PF. Value of repeat cytology at the time of colposcopy for the evaluation of cervical intraepithelial neoplasia on Papanicolaou smears. J Reprod Med 1989;34:815-7.
13. Simsir A, Ioffe OB, Bouequin P, Brooks SE, Henry M. Repeat cytology at the time of colposcopy. Is there added benefit? Acta Cytol 2001;45:23-7.
14. Pinto AP, Crum CC. Natural history of cervical neoplasia: Defining progression and its consequence. Clin Obstet Gynecol 2000;43:352-62.
15. Renshaw AA, Granter SR. Appropriate follow-up interval for biopsy confirmation of squamous intraepithelial lesions diagnosed by cervical smear cytology. Am J Clin Pathol 1997;108:275-9.
16. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH, for the 1992 National Cancer Institute Workshop. Interim guidelines for management of abnormal cervical cytology. JAMA 1994;271:1866-9.
17. Davison JM, Marty JJ. Detecting premalignant cervical lesions. Contributions of screening colposcopy to cytology. J Reprod Med 1994;39:388-92.
18. Nanda K, McCrory DC, Myers ER, Bastian LA, Haselbad V, Hickey JD, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review. Ann Intern Med 2000;132:810-9.
19. The 1991 Bethesda System for reporting cervical/vaginal cytological diagnoses. Diagn Cytopathol 1993;9:235-46.
20. Melnikow J, Nuovo J, Willan AR, Chan BKS, Howell LP. Natural history of cervical squamous intraepithelial lesions: A meta-analysis. Obstet Gynecol 1998;92:727-35.
21. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. for the Forum Group Members and the Bethesda 2001 workshop. The 2001 Bethesda System. Terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.
22. Alanen KW, Elit LM, Molinaro PA, McLachlin CM. Assessment of cytologic follow-up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions. Cancer 1998;84:5-10.
23. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ, for the 2001 ASCCP-sponsored Consesus Conference, 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-9.
24. Chin AB, Bristow RE, Korst LM, Walts A, Lagasse LD. The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population. Am J Obstet Gynecol 182:1278-82.
25. Chhieng DC, Elgert PA, Cangiarella JF, Cohen J-M. Clinical significance of atypical glandular cells of undetermined significance. A follow-up study from an academic medical center. Acta Cytol 2000;44:557-66.
26. Cheng RJ, Hernandez E, Anderson LL, Heller PB, Shank R. Clinical significance of a cytologic diagnosis of atypical glandular cells of undetermined significance. J Reprod Med 1999;44:922-8.
27. Patsner B, Morgan SA. The potential value of preoperative cytobrush Papanicolaou smear in clinical Stage I endometrial carcinoma. J Lower Gen Tract Dis 1999;3:4-6.
28. Patsner B. Atypical (favor neoplastic) glandular cells of undetermined significance: Report of two cases of occult adnexal malignancy in patients with "negative" workups. J Lower Gen Tract Dis 2002;6:1-3.
29. Maggi R, Zannoni E, Giorda G, Biraghi P, Sideri M. Comparison of repeat smear, colposcopy, and colposcopically directed biopsy in the evaluation of the mildly abnormal smear. Gynecol Oncol 1989;35:294-6.
30. Cox JT, Wilkinson EJ, Lonky N, Waxman A, Tosh R, Tedeschi C. ASCCP practice guidelines. Management guidelines for the follow-up of atypical squamous cells of undetermined significance (ASCUS). J Lower Gen Tract Dis 2000;4:99-105.
31. Cox JT, Massad LS, Lonky N, Tosh R, Waxman A, Wilkinson EJ. ASCCP practice guidelines. Management guidelines for the follow-up of cytology read as low grade squamous intraepithelial lesion. J Lower Gen Tract Dis 2000;4:83-92.
32. Young NA, Naryshkin S, Bowman RL. Value of repeat cervical smears at the time of colposcopic biopsy. Diagn Cytopathol 1993;9:646-9.
33. Higgins RV, Hall JB, McGee JA, Laurent S, Alvarez RD, Patridge EE. Appraisal of the modalities used to evaluate an initial abnormal Papanicolaou smear. Obstet Gynecol 1994;84:174-8.
34. Spitzer M, Ryskin M, Chernys AE, Shifrin A. The value of repeat Pap smear at the time of initial colposcopy. Gynecol Oncol 1997;67:3-7.
35. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, et al. Identifying women with cervical neoplasia. Using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999;281:1605-10.
36. Solomon D, Schiffman M, Tarone R. for the ALTS Group. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: Baseline results from a randomized trial. J Natl Cancer Inst 2001;93:293-9.
37. Hellberg D, Nilsson S, Valentin J. Positive cervical smear with subsequent normal colposcopy and histology - Frequency of CIN in a long-term follow-up. Gynecol Oncol 1994;53:148-51.
38. Guyatt GH, Sinclair J, Cook DJ, Glasziou P, for the Evidenced-Based Medicine Working Group and the Cochrane Applicability Methods Working Group. User's guides to the medical literature. XVI. How to use a treatment recommendation. JAMA 1999;281:1836-43.
39. American College of Obstetricians and Gynecologists. Cervical cytology screening. ACOG technology assessment in Obstet Gynecol no. 2. Obstet Gynecol 2002;100:1423-7.